Pubblicazioni

NRF2 activation in BONâ1 neuroendocrine cancerÂ cells reduces the cytotoxic effects of a novel Ruthenium(II)âcurcumin compound: A pilot study

2024 - ONCOLOGY REPORTS

Garufi, Alessia; Pettinari, Riccardo; Monteonofrio, Laura; Puliani, Giulia; Virdia, Ilaria; Appetecchia, Marialuisa; Marchetti, Fabio; Cirone, Mara; Soddu, Silvia; D'Orazi, Gabriella

NRF2 in Cancer: Cross-Talk with Oncogenic Pathways and Involvement in Gammaherpesvirus-Driven Carcinogenesis

2022 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cirone, Mara; D'Orazi, Gabriella

Lovastatin reduces PEL cell survival by phosphorylating ERK1/2 that blocks the autophagic flux and engages a cross-talk with p53 to activate p21

2021 - IUBMB LIFE

Santarelli, R.; Pompili, C.; Gilardini Montani, M. S.; Romeo, M. A.; Gonnella, R.; D'Orazi, G.; Cirone, M.

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

2019 - JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cirone, M.; Gilardini Montani, M. S.; Granato, M.; Garufi, A.; Faggioni, A.; D'Orazi, G.

Comparison of the effects of synthetic and plant-derived mTOR regulators on healthy human ovarian cells

2019 - EUROPEAN JOURNAL OF PHARMACOLOGY

Sirotkin, A. V.; Adamcova, E.; Rotili, D.; Mai, A.; Mlyncek, M.; Mansour, L.; Alwasel, S.; Harrath, A. H.

Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype

2016 - JOURNAL OF ALZHEIMER'S DISEASE

Tramutola, Antonella; Pupo, Gilda; Di Domenico, Fabio; Barone, Eugenio; Arena, Andrea; Lanzillotta, Chiara; Broekaart, Diede; Blarzino, Carla; Head, Elizabeth; Butterfield, D. Allan; Perluigi, Marzia